首页> 美国卫生研究院文献>Case Reports in Pulmonology >Metastatic Squamous Cell Carcinoma Component from an Adenosquamous Carcinoma of the Lung with Identical Epidermal Growth Factor Receptor Mutations
【2h】

Metastatic Squamous Cell Carcinoma Component from an Adenosquamous Carcinoma of the Lung with Identical Epidermal Growth Factor Receptor Mutations

机译:具有相同表皮生长因子受体突变的肺腺鳞癌的转移性鳞状细胞癌成分。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The case reported is a young “light” ex-smoker who initially had a localized adenosquamous carcinoma bearing an epidermal growth factor receptor (EGFR) sensitizing mutation. He first recurred six months after initial treatment within the brain with a pure squamous histology and the same EGFR mutation. Surgical resection and radiation rendered him disease-free. Subsequent isolated recurrence within the lung eighteen months later was a pure adenocarcinoma, again with the same identified EGFR mutation. These histologic changes (from adenosquamous to pure squamous to pure adenocarcinoma) have been described but not before in the absence of any selection pressure with EGFR tyrosine kinase inhibitors. This case points out the histologic “flexibility” of EGFR mutant lung cancers and the importance for appropriate molecular testing in nonsmokers with lung cancer of any histologic type.
机译:报道的病例是一个年轻的“轻”前吸烟者,他最初患有带有表皮生长因子受体(EGFR)致敏突变的局部腺鳞癌。最初接受治疗的六个月后,他首次在脑内复发,具有纯鳞状组织学和相同的EGFR突变。手术切除和放射使他无病。 18个月后,随后的肺内孤立性复发为纯腺癌,同样具有相同的EGFR突变。已经描述了这些组织学变化(从腺鳞状到纯鳞状到纯腺癌),但是在没有使用EGFR酪氨酸激酶抑制剂的任何选择压力的情况下没有描述过。该病例指出了EGFR突变型肺癌的组织学“灵活性”,以及在任何组织学类型的非吸烟者中进行适当分子检测的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号